Real-time enrollment status for this solid tumors harboring met amplification clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:22 PM UTC
| NCT Number | NCT07196644 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors Harboring MET Amplification |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 18 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | August 14, 2026 (Aug 14, 2026) |
As of October 12, 2026: Clinical trial NCT07196644 is currently recruiting participants. This phase2 study for solid tumors harboring met amplification is actively seeking new participants at 18 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07196644 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07196644 was last updated Aug 14, 2026 (August 14, 2026). HelloStudys verifies this status automatically.